Drug Type Gene editing |
Synonyms- |
Target |
Mechanism Hemoglobin gamma chain modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Ensoma, Inc.Startup |
Active Organization Ensoma, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anemia, Sickle Cell | Preclinical | US | Ensoma, Inc.Startup | - |
Beta-Thalassemia | Preclinical | US | Ensoma, Inc.Startup | - |